Document
National Center for Health Statistics, Meeting of the ICD-10 Coordination and Maintenance Committee
The Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, announces the followi...
SUPPLEMENTARY INFORMATION:
The Secretary of Health and Human Services (HHS) is statutorily required to maintain the U.S. domestic standards with public input and in a way that minimizes disruption and cost of compliance as described at 42 U.S. Code § 1395ww(d)(5)(K).
Purpose:
The ICD-10 Coordination and Maintenance (C&M) Committee is a public forum for the presentation of proposed modifications to the International Classification of Diseases, Tenth Revision, Clinical Modification (CM) and ICD-10 Procedure Coding System (PCS).
Matters to be Considered:
The tentative agenda will include discussions on the ICD-10-CM and ICD-10-PCS topics listed below. Agenda items are subject to change as priorities dictate. Please refer to the posted agenda for updates one month prior to the meeting.
ICD-10-PCS Topics:
1. Extracorporeal Interstitial Fluid Removal
2. Transcutaneous Spinal Cord Stimulation
3. Visually Guided Pressure Offloading
4. Percutaneous Irrigation for Intracranial Interventions
5. Measurement of Volumetric Blood Flow in Peripheral Vessels
6. Intraoperative Control of Pericardial Hemorrhage using Rapid Exchange Catheter
7. Monitoring of Peritoneal Cavity using Electrode Sensors
8. Labor Management
9. Sirolimus-Coated Balloon Catheter for Percutaneous Coronary Intervention
10. Computer-Aided Assessment of Acute Abdominopelvic Pathology
11. Computer-Aided Monitoring of Fluid Volume
12. Insertion of Brain Computer Interface Device
13. Fragmentation of Carotid Arteries
14. Computer-Aided Detection and Notification of Whole Body Positioning Status
15. Bypass using Endovascular Transvenous Cerebrospinal Fluid Shunt
16. Section X
17. Addenda and Reference Key Updates
18. Administration of cefepime-zidebactam
19. Administration of tanruprubart
20. Administration of ristoglogene autogetemcel
21. Transfusion of Cryopreserved Organ Donor-derived Bone Marrow
22. Administration of mivocabtagene autoleucel
23. Administration of anzutresgene autoleucel
24. Administration of imlifidase
CMS will not present the Fall 2026 ICD-10-PCS procedure code topics during a public meeting. Instead, CMS will post the procedure code topic materials and solicit public comments regarding any clinical questions or coding options. The deadline to submit comments for procedure code topics being considered for an April 1, 2027 implementation is October 16, 2026, and the deadline to submit comments for procedure code topics being considered for an October 1, 2027 implementation is November 13, 2026.
Members of the public should send any questions or comments related to the procedure code topics that are under consideration for an April 1, 2027 or an October 1, 2027 implementation to the CMS mailbox at:
ICDProcedureCodeRequest@cms.hhs.gov
by the respective deadline.
All procedure code topic materials and related documents will be made available on the CMS Website at
https://www.cms.gov/medicare/coding-billing/icd-10-codes/icd-10-coordination-maintenance-committee-materials. Additionally, CMS will post a question-and-answer document to address any clinical or coding questions that members of the public submit by the respective deadline.
ICD-10-CM Topics:
1. Adverse Childhood Experiences
2. Amyloid-related imaging abnormalities (ARIA)
3. Carotid Web
4. Doxy PEP
5. Encounter for Safety Counseling in the Home
6. Extreme Immaturity of Newborns
7. Limbal stem cell deficiency
8. Macular telangiectasia
9. Neonatal Supraventricular Tachycardia
10. Organizing Principles for Classification of Ultra-rare and Genetic Conditions
11. Presence of continuous glucose monitoring device
12. Progressive myopia
13. Sepsis
14. Tenosynovial Giant Cell Tumor
15. Addenda
The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign
Federal Register
notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.